What should you know about sarcoid PET scan?

A PET-CT combines metabolic information with detailed body imaging. The radiotracer FDG collects more noticeably in cells using glucose actively. Sarcoid inflammation can therefore appear as uptake in lymph nodes, lungs, or other affected areas. Cancer and infection can also produce uptake, so a bright area does not identify its cause on its own.

The scan may help map where inflammation is active, select a suitable site for further assessment, or compare findings over time. The report is read with symptoms, examination findings, prior scans, and laboratory results. In some cases, the pattern may resemble lymphoma or another cancer, which is why tissue sampling can remain relevant.

Follow the imaging centre's instructions about fasting, medicines, and activity before the appointment. Tell the team about diabetes, pregnancy or possible pregnancy, recent illness, and difficulty lying still. After the tracer is given, you will usually rest quietly before imaging, then lie on the scanner while pictures are collected.

Ask whether the scan is intended to assess sarcoid activity, investigate a new finding, or guide another test. Request an explanation of each reported uptake area and what would distinguish inflammation from another process. An FDG radiotracer is used for the metabolic part of the examination.

Tell staff immediately about breathing difficulty, faintness, or a new reaction after the tracer. After leaving, contact your care team for persistent vomiting, worsening breathlessness, chest pain, or other symptoms that concern you. Seek urgent care for severe breathing difficulty, collapse, or confusion; these symptoms should not wait for the scan report.

What question is this scan intended to answer? Which areas showed uptake? Could sarcoid inflammation explain the pattern? Is a biopsy needed? When will the report be reviewed with my previous imaging?